Is It Too Late To Consider Synopsys (SNPS) After Recent Share Price Strength?

• If you are wondering whether Synopsys at around US$432.65 is still a sensible entry or hold after its recent run, you are not alone. Valuation is where that question really gets tested.
• The stock has returned 2.0% over the last week and 1.4% over the last month, while the year to date return sits at a 9.9% decline and the 1 year return is 0.5%, with longer term 3 year and 5 year returns of 17.0% and 84.9% respectively.
• Recent coverage around Synopsys has focused on its role in software and tools for chip design and on how investors are thinking about the broader semiconductor and software ecosystem. That backdrop helps explain why the share price has moved modestly in the short term while longer term returns remain more substantial.
• Our valuation check framework gives Synopsys a score of 1 out of 6, which means only one of six checks currently points to the shares looking undervalued. Next we will look at how different valuation approaches interpret that score and then finish with a way of assessing value that goes beyond the usual ratios.

Synopsys scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Synopsys Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model takes estimates of the cash a business could generate in the future, then discounts those cash flows back into today’s dollars to arrive at an estimate of what the whole company might be worth right now.

For Synopsys, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flows in US$. The latest twelve month free cash flow sits at about $2.24b. Analysts provide explicit free cash flow estimates for several years, and Simply Wall St then extends those projections further out to year 10. By 2035, the extrapolated free cash flow used in the model is $6.04b, with discounted figures for each year between now and then.

Bringing all those projected cash flows back to today, the DCF model arrives at an estimated intrinsic value of about $391.63 per share. Compared with the current share price of roughly $432.65, this implies the stock screens as around 10.5% overvalued on this method.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Synopsys may be overvalued by 10.5%. Discover 48 high quality undervalued stocks or create your own screener to find better value opportunities.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Synopsys.

Approach 2: Synopsys Price vs Earnings

For a profitable company like Synopsys, the P/E ratio is a useful way to think about value because it links what you pay for each share to the earnings that support that share. In simple terms, a higher P/E can reflect higher growth expectations or a lower perception of risk, while a lower P/E can be associated with lower growth expectations or greater perceived risk.

Synopsys currently trades on a P/E of 74.98x. That sits well above the broader Software industry average of about 27.27x and also above the peer group average of 41.33x. On those simple comparisons alone, the shares look expensive relative to both the sector and closer peers.

Simply Wall St also calculates a proprietary “Fair Ratio” of 43.53x for Synopsys. This metric aims to be more tailored than a straight peer or industry comparison because it considers factors such as the company’s earnings growth profile, its industry, profit margins, market capitalization and identified risks. By tying the P/E that might be considered reasonable to these company specific inputs, the Fair Ratio can provide a more targeted reference point. Comparing Synopsys’ current P/E of 74.98x to the Fair Ratio of 43.53x suggests the shares trade above the level this framework would consider aligned with those fundamentals.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Synopsys Narrative

Earlier we mentioned that there is an even better way to understand valuation. Let us introduce you to Narratives, where you set out your own story for Synopsys on Simply Wall St’s Community page. You do this by linking what you believe about its business, such as the impact of the Ansys acquisition, SaaS and cloud adoption or risks around EDA and IP, to explicit forecasts for revenue, earnings and margins. These then roll into a Fair Value you can compare to the current share price to help you decide whether Synopsys looks closer to a buy or a sell in your view. That Fair Value updates as new information like earnings or news arrives. For example, one investor might build a more optimistic Synopsys Narrative that lands near the higher analyst fair value area of about US$715, while another might lean toward the lower end around US$550. The platform simply keeps those stories and numbers in sync for you.

Do you think there's more to the story for Synopsys? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com